American Thoracic, S., and Infectious Diseases Society of, A. (2005). Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171, 388-416.
Angus, D.C., and van der Poll, T. (2013). Severe sepsis and septic shock. N Engl J Med 369, 840-851.
Anjan, V.Y., Loftus, T.M., Burke, M.A., Akhter, N., Fonarow, G.C., Gheorghiade, M., and Shah, S.J. (2012). Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction. Am J Cardiol 110, 870-876.
Barandiaran Aizpurua, A., Sanders-van Wijk, S., Brunner-La Rocca, H.P., Henkens, M., Heymans, S., Beussink-Nelson, L., Shah, S.J., and van Empel, V.P.M. (2020). Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fraction. Eur J Heart Fail 22, 413-421.
Braunwald, E. (2013). Heart failure. JACC Heart Fail 1, 1-20.
Chawla, R. (2008). Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries. Am J Infect Control 36, S93-100.
Churchill, T.W., Li, S.X., Curreri, L., Zern, E.K., Lau, E.S., Liu, E.E., Farrell, R., Shoenike, M.W., Sbarbaro, J., Malhotra, R., et al. (2021). Evaluation of 2 Existing Diagnostic Scores for Heart Failure With Preserved Ejection Fraction Against a Comprehensively Phenotyped Cohort. Circulation 143, 289-291.
Corrales-Medina, V.F., Alvarez, K.N., Weissfeld, L.A., Angus, D.C., Chirinos, J.A., Chang, C.C., Newman, A., Loehr, L., Folsom, A.R., Elkind, M.S., et al. (2015). Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA 313, 264-274.
Corrales-Medina, V.F., Musher, D.M., Shachkina, S., and Chirinos, J.A. (2013). Acute pneumonia and the cardiovascular system. Lancet 381, 496-505.
Corrales-Medina, V.F., Musher, D.M., Wells, G.A., Chirinos, J.A., Chen, L., and Fine, M.J. (2012). Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 125, 773-781.
Cowie, M.R., Komajda, M., Murray-Thomas, T., Underwood, J., Ticho, B., and Investigators, P. (2006). Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 27, 1216-1222.
Dhingra, A., Garg, A., Kaur, S., Chopra, S., Batra, J.S., Pandey, A., Chaanine, A.H., and Agarwal, S.K. (2014). Epidemiology of heart failure with preserved ejection fraction. Curr Heart Fail Rep 11, 354-365.
Faxen, U.L., Venkateshvaran, A., Shah, S.J., Lam, C.S.P., Svedlund, S., Saraste, A., Beussink-Nelson, L., Lagerstrom Fermer, M., Gan, L.M., Hage, C., et al. (2021). Generalizability of HFA-PEFF and H2FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF. J Card Fail 27, 756-765.
Forman, D.E., Butler, J., Wang, Y., Abraham, W.T., O'Connor, C.M., Gottlieb, S.S., Loh, E., Massie, B.M., Rich, M.W., Stevenson, L.W., et al. (2004). Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43, 61-67.
Giuliano, K.K., Baker, D., and Quinn, B. (2018). The epidemiology of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control 46, 322-327.
Haass, M., Kitzman, D.W., Anand, I.S., Miller, A., Zile, M.R., Massie, B.M., and Carson, P.E. (2011). Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail 4, 324-331.
Hamatani, Y., Nagai, T., Nakai, M., Nishimura, K., Honda, Y., Nakano, H., Honda, S., Iwakami, N., Sugano, Y., Asaumi, Y., et al. (2018). Elevated Plasma D-Dimer Level Is Associated With Short-Term Risk of Ischemic Stroke in Patients With Acute Heart Failure. Stroke 49, 1737-1740.
Harrell, F.E., Jr., Califf, R.M., Pryor, D.B., Lee, K.L., and Rosati, R.A. (1982). Evaluating the yield of medical tests. JAMA 247, 2543-2546.
Ignacio de Ulibarri, J., Gonzalez-Madrono, A., de Villar, N.G., Gonzalez, P., Gonzalez, B., Mancha, A., Rodriguez, F., and Fernandez, G. (2005). CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 20, 38-45.
Iwakami, N., Nagai, T., Furukawa, T.A., Sugano, Y., Honda, S., Okada, A., Asaumi, Y., Aiba, T., Noguchi, T., Kusano, K., et al. (2017). Prognostic value of malnutrition assessed by Controlling Nutritional Status score for long-term mortality in patients with acute heart failure. Int J Cardiol 230, 529-536.
Kapoor, J.R., and Heidenreich, P.A. (2010). Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. Am Heart J 159, 75-80.
Kasahara, S., Sakata, Y., Nochioka, K., Yamauchi, T., Onose, T., Tsuji, K., Abe, R., Oikawa, T., Sato, M., Aoyanagi, H., et al. (2018). Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 Study. Heart Vessels 33, 997-1007.
Komatsu, R., Okazaki, T., Ebihara, S., Kobayashi, M., Tsukita, Y., Nihei, M., Sugiura, H., Niu, K., Ebihara, T., and Ichinose, M. (2018). Aspiration pneumonia induces muscle atrophy in the respiratory, skeletal, and swallowing systems. J Cachexia Sarcopenia Muscle 9, 643-653.
Lancellotti, P., Galderisi, M., Edvardsen, T., Donal, E., Goliasch, G., Cardim, N., Magne, J., Laginha, S., Hagendorff, A., Haland, T.F., et al. (2017). Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study. Eur Heart J Cardiovasc Imaging 18, 961-968.
Lynch, J.P., 3rd (2001). Hospital-acquired pneumonia: risk factors, microbiology, and treatment. Chest 119, 373S-384S.
Magill, S.S., Edwards, J.R., Bamberg, W., Beldavs, Z.G., Dumyati, G., Kainer, M.A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014). Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370, 1198-1208.
Mankowski, R.T., Yende, S., and Angus, D.C. (2019). Long-term impact of sepsis on cardiovascular health. Intensive Care Med 45, 78-81.
Massie, B.M., O'Connor, C.M., Metra, M., Ponikowski, P., Teerlink, J.R., Cotter, G., Weatherley, B.D., Cleland, J.G., Givertz, M.M., Voors, A., et al. (2010). Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 363, 1419-1428.
McKee, P.A., Castelli, W.P., McNamara, P.M., and Kannel, W.B. (1971). The natural history of congestive heart failure: the Framingham study. N Engl J Med 285, 1441- 1446.
Merx, M.W., and Weber, C. (2007). Sepsis and the heart. Circulation 116, 793-802.
Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., de Ferranti, S., Despres, J.P., Fullerton, H.J., Howard, V.J., et al. (2015). Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 131, e29-322.
Murad, K., and Kitzman, D.W. (2012). Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management. Heart Fail Rev 17, 581-588.
Nagai, T., Nishimura, K., Honma, T., Higashiyama, A., Sugano, Y., Nakai, M., Honda, S., Iwakami, N., Okada, A., Kawakami, S., et al. (2016). Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure. Eur J Heart Fail 18, 803-813.
Nagai, T., Yoshikawa, T., Saito, Y., Takeishi, Y., Yamamoto, K., Ogawa, H., Anzai, T., and Investigators, J. (2018). Clinical Characteristics, Management, and Outcomes of Japanese Patients Hospitalized for Heart Failure With Preserved Ejection Fraction- A Report From the Japanese Heart Failure Syndrome With Preserved Ejection Fraction (JASPER) Registry. Circ J 82, 1534-1545.
Obokata, M., Reddy, Y.N.V., Pislaru, S.V., Melenovsky, V., and Borlaug, B.A. (2017). Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction. Circulation 136, 6-19.
Pieske, B., Tschope, C., de Boer, R.A., Fraser, A.G., Anker, S.D., Donal, E., Edelmann, F., Fu, M., Guazzi, M., Lam, C.S.P., et al. (2020). How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 22, 391-412.
Ponikowski, P., Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G.F., Coats, A.J.S., Falk, V., Gonzalez-Juanatey, J.R., Harjola, V.P., Jankowska, E.A., et al. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37, 2129-2200.
Reddy, Y.N.V., Carter, R.E., Obokata, M., Redfield, M.M., and Borlaug, B.A. (2018). A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation 138, 861-870.
Redfield, M.M. (2016). Heart Failure with Preserved Ejection Fraction. N Engl J Med 375, 1868-1877.
Roberts, E., Ludman, A.J., Dworzynski, K., Al-Mohammad, A., Cowie, M.R., McMurray, J.J., Mant, J., and Failure, N.G.D.G.f.A.H. (2015). The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ 350, h910.
Rotstein, C., Evans, G., Born, A., Grossman, R., Light, R.B., Magder, S., McTaggart, B., Weiss, K., and Zhanel, G.G. (2008). Clinical practice guidelines for hospital- acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol 19, 19-53.
Seo, Y., Ishizu, T., Ieda, M., Ohte, N., and Investigators, J.L.S. (2021). Clinical Usefulness of the HFA-PEFF Diagnostic Scoring System in Identifying Late Elderly Heart Failure With Preserved Ejection Fraction Patients. Circ J 85, 604- 611.
Sepehrvand, N., Alemayehu, W., Dyck, G.J.B., Dyck, J.R.B., Anderson, T., Howlett, J., Paterson, I., McAlister, F.A., and Ezekowitz, J.A. (2019). External Validation of the H2F-PEF Model in Diagnosing Patients With Heart Failure and Preserved Ejection Fraction. Circulation 139, 2377-2379.
Shah, S.J., Kitzman, D.W., Borlaug, B.A., van Heerebeek, L., Zile, M.R., Kass, D.A., and Paulus, W.J. (2016). Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap. Circulation 134, 73-90.
Shimokawa, H., Miura, M., Nochioka, K., and Sakata, Y. (2015). Heart failure as a general pandemic in Asia. Eur J Heart Fail 17, 884-892.
Sopena, N., Sabria, M., and Neunos Study, G. (2005). Multicenter study of hospital- acquired pneumonia in non-ICU patients. Chest 127, 213-219.
Takemoto, Y., Barnes, M.E., Seward, J.B., Lester, S.J., Appleton, C.A., Gersh, B.J., Bailey, K.R., and Tsang, T.S. (2005). Usefulness of left atrial volume in predicting first congestive heart failure in patients > or = 65 years of age with well-preserved left ventricular systolic function. Am J Cardiol 96, 832-836.
Teerlink, J.R., Cotter, G., Davison, B.A., Felker, G.M., Filippatos, G., Greenberg, B.H., Ponikowski, P., Unemori, E., Voors, A.A., Adams, K.F., Jr., et al. (2013). Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381, 29-39.
Teng, T.K., Cooper, L., Tay, W.T., Luo, N., Sharma, A., Whellan, D., Anand, I., Pina, I.L., Tromp, J., Richards, A.M., et al. (2020). Association between body surface area and prescribed doses of guideline-directed medications among international patients with heart failure and reduced ejection fraction. Eur J Heart Fail 22, 754- 758.
Tromp, J., Tay, W.T., Ouwerkerk, W., Teng, T.K., Yap, J., MacDonald, M.R., Leineweber, K., McMurray, J.J.V., Zile, M.R., Anand, I.S., et al. (2018). Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry. PLoS Med 15, e1002541.
Tsang, T.S., Abhayaratna, W.P., Barnes, M.E., Miyasaka, Y., Gersh, B.J., Bailey, K.R., Cha, S.S., and Seward, J.B. (2006). Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol 47, 1018-1023.
Vasan, R.S., and Levy, D. (2000). Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 101, 2118-2121.
Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E., Jr., Colvin, M.M., Drazner, M.H., Filippatos, G.S., Fonarow, G.C., Givertz, M.M., et al. (2017). 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 136, e137-e161.
Yende, S., D'Angelo, G., Kellum, J.A., Weissfeld, L., Fine, J., Welch, R.D., Kong, L., Carter, M., Angus, D.C., and Gen, I.M.S.I. (2008). Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 177, 1242-1247.
Yende, S., D'Angelo, G., Mayr, F., Kellum, J.A., Weissfeld, L., Kaynar, A.M., Young, T., Irani, K., Angus, D.C., and Gen, I.M.S.I. (2011). Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths. PLoS One 6, e22847.